IMPROVEMENT OF CARDIOVASCULAR-DISEASE RISK-FACTORS IN OBESE-DIABETIC AND NONDIABETIC PATIENTS AFTER 12 MONTHS OF PHENTERMINE FENFLURAMINE (PHEN/FEN) THERAPY/
Ma. Khan et al., IMPROVEMENT OF CARDIOVASCULAR-DISEASE RISK-FACTORS IN OBESE-DIABETIC AND NONDIABETIC PATIENTS AFTER 12 MONTHS OF PHENTERMINE FENFLURAMINE (PHEN/FEN) THERAPY/, The American journal of clinical nutrition, 66(1), 1997, pp. 111-111